These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9651909)

  • 1. Comparison of the transdermal delivery of estradiol from two gel formulations.
    Walters KA; Brain KR; Green DM; James VJ; Watkinson AC; Sands RH
    Maturitas; 1998 Jun; 29(2):189-95. PubMed ID: 9651909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol.
    Scott RT; Ross B; Anderson C; Archer DF
    Obstet Gynecol; 1991 May; 77(5):758-64. PubMed ID: 2014092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estrogen replacement therapy with oestrogel].
    Pekhlivanov B
    Akush Ginekol (Sofiia); 2003; 42(4):38-41. PubMed ID: 14577367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative absorption and variability in absorption of estradiol from a transdermal gel and a novel matrix-type transdermal patch.
    Järvinen A; Bäckström A; Elfström C; Viitanen A
    Maturitas; 2001 Apr; 38(2):189-96. PubMed ID: 11306208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microemulsions for topical delivery of estradiol.
    Peltola S; Saarinen-Savolainen P; Kiesvaara J; Suhonen TM; Urtti A
    Int J Pharm; 2003 Mar; 254(2):99-107. PubMed ID: 12623186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal hormone therapy: gels and patches.
    Samsioe G
    Climacteric; 2004 Dec; 7(4):347-56. PubMed ID: 15799606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the transdermal absorption of nimesulide from three commercially available gel formulations.
    Dayal P; Kanikkannan N; Singh A; Sing M
    Drug Dev Ind Pharm; 2002 Mar; 28(3):297-304. PubMed ID: 12026222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical oleo-hydrogel preparation of ketoprofen with enhanced skin permeability.
    Rhee GJ; Woo JS; Hwang SJ; Lee YW; Lee CH
    Drug Dev Ind Pharm; 1999 Jun; 25(6):717-26. PubMed ID: 10349557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal dual-controlled delivery of contraceptive drugs: formulation development, in vitro and in vivo evaluations, and clinical performance.
    Chien YW; Chien TY; Bagdon RE; Huang YC; Bierman RH
    Pharm Res; 1989 Dec; 6(12):1000-10. PubMed ID: 2516312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sucrose laurate gels as a percutaneous delivery system for oestradiol in rabbits.
    Vermeire A; De Muynck C; Vandenbossche G; Eechaute W; Geerts ML; Remon JP
    J Pharm Pharmacol; 1996 May; 48(5):463-7. PubMed ID: 8799868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption and bioavailability of oestradiol from a gel, a patch and a tablet.
    Järvinen A; Nykänen S; Paasiniemi L
    Maturitas; 1999 Jun; 32(2):103-13. PubMed ID: 10465378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
    Baker VL
    Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous estradiol permeation, penetration and metabolism in pig and man.
    Mahmoud A; Haberland A; Dürrfeld M; Heydeck D; Wagner S; Schafer-Korting M
    Skin Pharmacol Physiol; 2005; 18(1):27-35. PubMed ID: 15608500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems.
    Yang Y; Manda P; Pavurala N; Khan MA; Krishnaiah YS
    J Control Release; 2015 Jul; 210():58-66. PubMed ID: 25979329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kinetics of a new patch for transdermal administration of 17 beta-estradiol].
    Rohr UD; Nauert C; Ehrly AM
    Zentralbl Gynakol; 1995; 117(10):531-9. PubMed ID: 7491836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeation Efficacy of a Transdermal Vehicle with Steroidal Hormones and Nonsteroidal Anti-inflammatory Agents as Model Drugs.
    Junqueira LA; Polonini H; Loures S; Raposo NRB; Ferreira AO; Brandão MAF
    Curr Drug Deliv; 2019; 16(2):136-141. PubMed ID: 30360741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dose on the absorption of estradiol from a transdermal gel.
    Järvinen A; Granander M; Laine T; Viitanen A
    Maturitas; 2000 Apr; 35(1):51-6. PubMed ID: 10802400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle delivery for transdermal HRT.
    Valenzuela P; Simon JA
    Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics of oestradiol gel in post-menopausal women: effects of application area and washing.
    Järvinen A; Granander M; Nykänen S; Laine T; Geurts P; Viitanen A
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():14-8. PubMed ID: 9389778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
    Balfour JA; Heel RC
    Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.